{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:01:04Z","timestamp":1780984864110,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"DOI":"10.1007\/s12105-026-01932-0","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:33:48Z","timestamp":1780983228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Salivary Gland Carcinoma with DLG1::BRAF Gene Fusion: Report of a Case"],"prefix":"10.1007","volume":"20","author":[{"given":"Jose G.","family":"Mantilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matija","family":"Snuderl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Z.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"2","key":"1932_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/his.15289","volume":"86","author":"RA Wolk","year":"2025","unstructured":"Wolk RA, Cipriani NA (2025) Update of newly-recognized salivary gland neoplasms: molecular and immunohistochemical findings and clinical importance. Histopathology 86(2):183\u2013198","journal-title":"Histopathology"},{"issue":"5","key":"1932_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/jcp-2024-209859","volume":"78","author":"JA Bishop","year":"2025","unstructured":"Bishop JA (2025) Fusions in salivary gland neoplasms: a review of practical diagnostic applications. J Clin Pathol 78(5):289\u2013297","journal-title":"J Clin Pathol"},{"issue":"6","key":"1932_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/PAP.0b013e3182a92cc3","volume":"20","author":"I Weinreb","year":"2013","unstructured":"Weinreb I (2013) Translocation-associated salivary gland tumors: a review and update. Adv Anat Pathol 20(6):367\u2013377","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"1932_CR4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/his.14296","volume":"79","author":"JA Bishop","year":"2021","unstructured":"Bishop JA, Nakaguro M, Whaley RD, Ogura K, Imai H, Laklouk I et al (2021) Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33-RET fusions and BRAF V600E mutations. Histopathology 79(3):338\u2013346","journal-title":"Histopathology"},{"issue":"4","key":"1932_CR5","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1007\/s12105-021-01331-7","volume":"15","author":"JA Bishop","year":"2021","unstructured":"Bishop JA, Sajed DP, Weinreb I, Dickson BC, Bilodeau EA, Agaimy A et al (2021) Microsecretory adenocarcinoma of salivary glands: an expanded series of 24 cases. Head Neck Pathol 15(4):1192\u20131201","journal-title":"Head Neck Pathol"},{"issue":"2","key":"1932_CR6","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/PAS.0000000000000980","volume":"42","author":"A Sk\u00e1lov\u00e1","year":"2018","unstructured":"Sk\u00e1lov\u00e1 A, Stenman G, Simpson RHW, Hellquist H, Slouka D, Svoboda T et al (2018) The role of molecular testing in the differential diagnosis of salivary gland carcinomas. Am J Surg Pathol 42(2):e11\u2013e27","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1932_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.path.2020.10.002","volume":"14","author":"M Nakaguro","year":"2021","unstructured":"Nakaguro M, Nagao T (2021) Epithelial-myoepithelial carcinoma. Surg Pathol Clin 14(1):97\u2013109","journal-title":"Surg Pathol Clin"},{"issue":"1","key":"1932_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.humpath.2014.08.017","volume":"46","author":"N Katabi","year":"2015","unstructured":"Katabi N, Ghossein R, Ho A, Dogan S, Zhang L, Sung YS et al (2015) Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts. Hum Pathol 46(1):26\u201333","journal-title":"Hum Pathol"},{"issue":"7","key":"1932_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.oraloncology.2011.04.020","volume":"47","author":"K Bj\u00f8rndal","year":"2011","unstructured":"Bj\u00f8rndal K, Krogdahl A, Therkildsen MH, Overgaard J, Johansen J, Kristensen CA et al (2011) Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol 47(7):677\u2013682","journal-title":"Oral Oncol"},{"issue":"7","key":"1932_CR10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S1368-8375(02)00007-6","volume":"38","author":"P Wahlberg","year":"2002","unstructured":"Wahlberg P, Anderson H, Bi\u00f6rklund A, M\u00f6ller T, Perfekt R (2002) Carcinoma of the parotid and submandibular glands--a study of survival in 2465 patients. Oral Oncol 38(7):706\u2013713","journal-title":"Oral Oncol"},{"issue":"12","key":"1932_CR11","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.5858\/2004-128-1385-SANOSA","volume":"128","author":"J Li","year":"2004","unstructured":"Li J, Wang BY, Nelson M, Li L, Hu Y, Urken ML et al (2004) Salivary adenocarcinoma, not otherwise specified: a collection of orphans. Arch Pathol Lab Med 128(12):1385\u20131394","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"1932_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.opresp.2022.100227","volume":"5","author":"A Rodr\u00edguez Perojo","year":"2023","unstructured":"Rodr\u00edguez Perojo A, Raboso Moreno B, Garc\u00eda SP, Somolinos De Marcos MN, Gil Alcalde M, Rio Ram\u00edrez MT (2023) Posterior mediastinum plasmocytoma: an infrequent location. Open Respir Arch 5(1):100227","journal-title":"Open Respir Arch"},{"issue":"5","key":"1932_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","volume":"34","author":"A Sk\u00e1lov\u00e1","year":"2010","unstructured":"Sk\u00e1lov\u00e1 A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B et al (2010) Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 34(5):599\u2013608","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"1932_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.70083","volume":"64","author":"A Agaimy","year":"2025","unstructured":"Agaimy A, Dermawan JK, Rios E, Meidenbauer N, Dimmler A, Stoehr R et al (2025) NFATC2::NUTM2A\/B fusions characterize a novel indolent myoepithelial-like neoplasm of the lungs and salivary glands. Genes Chromosomes Cancer 64(9):e70083","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"1932_CR15","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/his.15380","volume":"86","author":"YH Chu","year":"2025","unstructured":"Chu YH, Katabi N, Sukhadia P, Mullaney KA, Zaidinski M, Cracchiolo JR et al (2025) Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions. Histopathology 86(5):728\u2013741","journal-title":"Histopathology"},{"issue":"11","key":"1932_CR16","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1097\/PAS.0000000000001133","volume":"42","author":"A Sk\u00e1lov\u00e1","year":"2018","unstructured":"Sk\u00e1lov\u00e1 A, Vanecek T, Uro-Coste E, Bishop JA, Weinreb I, Thompson LDR et al (2018) Molecular profiling of salivary gland intraductal carcinoma revealed a subset of tumors harboring NCOA4-RET and novel TRIM27-RET fusions: a report of 17 cases. Am J Surg Pathol 42(11):1445\u20131455","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1932_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/his.14251","volume":"79","author":"C Taverna","year":"2021","unstructured":"Taverna C, Ban\u011b\u010dkov\u00e1 M, Lorenzon M, Palomba A, Franchi A, Skalova A et al (2021) MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics. Histopathology 79(3):315\u2013324","journal-title":"Histopathology"},{"issue":"1","key":"1932_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PAS.0000000000002475","volume":"50","author":"D Al-Sajee","year":"2026","unstructured":"Al-Sajee D, Rooper LM, Bishop JA, Bell D, Dogan S, Xu B et al (2026) Fenestrating adenocarcinoma: a novel salivary gland cancer with EWSR1::BEND2 fusion and predilection for the Pharynx. Am J Surg Pathol 50(1):12\u201320","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"1932_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01501-23","volume":"97","author":"H Chang","year":"2023","unstructured":"Chang H, Wu H, Hou P, Aizaz M, Yang R, Xiang A et al (2023) DLG1 promotes the antiviral innate immune response by inhibiting p62-mediated autophagic degradation of IKK\u03b5. J Virol 97(12):e0150123","journal-title":"J Virol"},{"key":"1932_CR20","doi-asserted-by":"crossref","unstructured":"d'Apolito M, Santoro F, Santacroce R, Cordisco G, Ragnatela I, D'Arienzo G, et al. A novel DLG1 variant in a family with Brugada syndrome: clinical characteristics and in silico analysis. Genes 2023; 14(2).","DOI":"10.3390\/genes14020427"},{"issue":"2","key":"1932_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/his.14940","volume":"83","author":"T Kervarrec","year":"2023","unstructured":"Kervarrec T, Pissaloux D, Paindavoine S, Tirode F, Osio A, Mourah S et al (2023) Recurrent PAK2 rearrangements in poroma with folliculo-sebaceous differentiation. Histopathology 83(2):310\u2013319","journal-title":"Histopathology"},{"issue":"14","key":"1932_CR22","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1158\/0008-5472.CAN-16-3563","volume":"77","author":"WP Kloosterman","year":"2017","unstructured":"Kloosterman WP, Coebergh van den Braak RRJ, Pieterse M, van Roosmalen MJ, Sieuwerts AM, Stangl C et al (2017) A systematic analysis of oncogenic gene fusions in primary colon cancer. Cancer Res 77(14):3814\u20133822","journal-title":"Cancer Res"},{"issue":"4","key":"1932_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1158\/1541-7786.MCR-19-0529","volume":"18","author":"C Stangl","year":"2020","unstructured":"Stangl C, Post JB, van Roosmalen MJ, Hami N, Verlaan-Klink I, Vos HR et al (2020) Diverse BRAF gene fusions confer resistance to EGFR-targeted therapy via differential modulation of BRAF activity. Mol Cancer Res 18(4):537\u2013548","journal-title":"Mol Cancer Res"},{"key":"1932_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-85","volume":"10","author":"PA Ascierto","year":"2012","unstructured":"Ascierto PA, Kirkwood JM, Grob JJ, Simeone E, Grimaldi AM, Maio M et al (2012) The role of BRAF V600 mutation in melanoma. J Transl Med 10:85","journal-title":"J Transl Med"},{"issue":"1","key":"1932_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/CCO.0000000000000797","volume":"34","author":"RS Scheffel","year":"2022","unstructured":"Scheffel RS, Dora JM, Maia AL (2022) BRAF mutations in thyroid cancer. Curr Opin Oncol 34(1):9\u201318","journal-title":"Curr Opin Oncol"},{"key":"1932_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225593","author":"MN Mamat Yusof","year":"2022","unstructured":"Mamat Yusof MN, Ch\u2019ng ES, Radhiah Abdul Rahman N (2022) BRAF V600E mutation in ameloblastoma: a systematic review and meta-analysis. Cancers. https:\/\/doi.org\/10.3390\/cancers14225593","journal-title":"Cancers"},{"key":"1932_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.humpath.2022.08.005","volume":"129","author":"EY Kao","year":"2022","unstructured":"Kao EY, Wakeman KM, Wu Y, Gross JM, Chen EY, Ricciotti RW et al (2022) Prevalence and detection of actionable BRAF V600 and NRAS Q61 mutations in malignant peripheral nerve sheath tumor by droplet digital PCR. Hum Pathol 129:90\u201397","journal-title":"Hum Pathol"},{"issue":"24","key":"1932_CR28","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1038\/s41388-018-0171-x","volume":"37","author":"M Dankner","year":"2018","unstructured":"Dankner M, Rose AAN, Rajkumar S, Siegel PM, Watson IR (2018) Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations. Oncogene 37(24):3183\u20133199","journal-title":"Oncogene"},{"issue":"5","key":"1932_CR29","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1158\/2159-8290.CD-19-1265","volume":"10","author":"V Subbiah","year":"2020","unstructured":"Subbiah V, Puzanov I, Blay JY, Chau I, Lockhart AC, Raje NS et al (2020) Pan-cancer efficacy of Vemurafenib in BRAF (V600)-mutant non-melanoma cancers. Cancer Discov 10(5):657\u2013663","journal-title":"Cancer Discov"},{"issue":"4","key":"1932_CR30","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/ijc.29825","volume":"138","author":"JS Ross","year":"2016","unstructured":"Ross JS, Wang K, Chmielecki J, Gay L, Johnson A, Chudnovsky J et al (2016) The distribution of BRAF gene fusions in solid tumors and response to targeted therapy. Int J Cancer 138(4):881\u2013890","journal-title":"Int J Cancer"},{"issue":"21","key":"1932_CR31","doi-asserted-by":"publisher","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","volume":"68","author":"DT Jones","year":"2008","unstructured":"Jones DT, Kocialkowski S, Liu L, Pearson DM, B\u00e4cklund LM, Ichimura K et al (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68(21):8673\u20138677","journal-title":"Cancer Res"},{"issue":"1","key":"1932_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1172\/JCI23237","volume":"115","author":"R Ciampi","year":"2005","unstructured":"Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova MN et al (2005) Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 115(1):94\u2013101","journal-title":"J Clin Invest"},{"key":"1932_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-7-8","volume":"7","author":"V Subbiah","year":"2014","unstructured":"Subbiah V, Westin SN, Wang K, Araujo D, Wang WL, Miller VA et al (2014) Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein. J Hematol Oncol 7:8","journal-title":"J Hematol Oncol"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-026-01932-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-026-01932-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-026-01932-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:33:52Z","timestamp":1780983232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-026-01932-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1932"],"URL":"https:\/\/doi.org\/10.1007\/s12105-026-01932-0","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a single case report, and no experimental procedures were performed on this patient. IRB approval is not required for such cases at our institution. All identifiable patient information has been removed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This study is based only on Pathology findings and all potentially identifiable information has been removed. Individual patient consent has not been obtained for this individual case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate and Consent for Publication"}}],"article-number":"64"}}